NovaBay Pharmaceuticals Inc (NBY)
0.3296
-0.01 (-3.60%)
USD |
NYAM |
Aug 09, 09:44
NovaBay Pharmaceuticals Cash from Investing (TTM): -12.04M for March 31, 2022
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2022 | -12.04M |
December 31, 2021 | -12.04M |
September 30, 2021 | -0.065M |
June 30, 2021 | -0.053M |
March 31, 2021 | -0.051M |
December 31, 2020 | -0.026M |
September 30, 2020 | -0.005M |
June 30, 2020 | 0.00 |
March 31, 2020 | -0.005M |
December 31, 2019 | -0.019M |
September 30, 2019 | -0.05M |
June 30, 2019 | -0.058M |
March 31, 2019 | -0.056M |
December 31, 2018 | -0.044M |
September 30, 2018 | -0.029M |
June 30, 2018 | -0.094M |
March 31, 2018 | -0.187M |
December 31, 2017 | -0.244M |
September 30, 2017 | -0.31M |
June 30, 2017 | -0.277M |
March 31, 2017 | -0.203M |
December 31, 2016 | -0.16M |
September 30, 2016 | -0.155M |
June 30, 2016 | -0.139M |
March 31, 2016 | -0.125M |
Date | Value |
---|---|
December 31, 2015 | -0.086M |
September 30, 2015 | 1.256M |
June 30, 2015 | 3.794M |
March 31, 2015 | 4.945M |
December 31, 2014 | 2.598M |
September 30, 2014 | 2.556M |
June 30, 2014 | 0.956M |
March 31, 2014 | -0.231M |
December 31, 2013 | 1.407M |
September 30, 2013 | 0.61M |
June 30, 2013 | 0.69M |
March 31, 2013 | 0.213M |
December 31, 2012 | 1.363M |
September 30, 2012 | -2.598M |
June 30, 2012 | -4.559M |
March 31, 2012 | -4.584M |
December 31, 2011 | -4.665M |
September 30, 2011 | -1.058M |
June 30, 2011 | -0.658M |
March 31, 2011 | -0.219M |
December 31, 2010 | -1.194M |
September 30, 2010 | -0.689M |
June 30, 2010 | 1.211M |
March 31, 2010 | 1.006M |
December 31, 2009 | -1.069M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-12.04M
Minimum
Dec 2021
--
Maximum
Jun 2020
-1.336M
Average
-0.053M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
ContraFect Corp | -11.78M |
Arcutis Biotherapeutics Inc | 94.83M |
Palatin Technologies Inc | -0.2243M |
iBio Inc | -8.512M |
Synthetic Biologics Inc | -4.28M |